The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Genetically modified pig kidneys begin trials for 50 U.S. kidney failure patients FDA launches clinical trials for organ ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA has approved clinical trials for organ transplants using genetically modified pigs, starting with six patients with ...

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and ...